{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:46:52Z","timestamp":1792622812909,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T00:00:00Z","timestamp":1499385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T00:00:00Z","timestamp":1499385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The collagen- and calcium-binding EGF domains 1 (CCBE1) protein is necessary for lymphangiogenesis. Its C-terminal collagen-like domain was shown to be required for the activation of the major lymphangiogenic growth factor VEGF-C (Vascular Endothelial Growth Factor-C) along with the ADAMTS3 (A Disintegrin And Metalloproteinase with Thrombospondin Motifs-3) protease. However, it remained unclear how the N-terminal domain of CCBE1 contributed to lymphangiogenic signaling. Here, we show that efficient activation of VEGF-C requires its C-terminal domain both <jats:italic>in vitro<\/jats:italic> and in a transgenic mouse model. The N-terminal EGF-like domain of CCBE1 increased VEGFR-3 signaling by colocalizing pro-VEGF-C with its activating protease to the lymphatic endothelial cell surface. When the\u00a0ADAMTS3 amounts were limited, proteolytic activation of pro-VEGF-C was supported by the N-terminal domain of CCBE1, but not by its C-terminal domain. A single amino acid substitution in ADAMTS3, identified from a lymphedema patient, was associated with abnormal CCBE1 localization. These results show that CCBE1 promotes VEGFR-3 signaling and lymphangiogenesis by different mechanisms, which are mediated independently by the two domains of CCBE1: by enhancing the cleavage activity of ADAMTS3 and by facilitating the colocalization of VEGF-C and ADAMTS3. These new insights should be valuable in developing new strategies to therapeutically target VEGF-C\/VEGFR-3-induced lymphangiogenesis.<\/jats:p>","DOI":"10.1038\/s41598-017-04982-1","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T14:52:29Z","timestamp":1499093549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1898-4928","authenticated-orcid":false,"given":"Sawan Kumar","family":"Jha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushbu","family":"Rauniyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terhi","family":"Karpanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veli-Matti","family":"Lepp\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9548-8229","authenticated-orcid":false,"given":"Pascal","family":"Brouillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miikka","family":"Vikkula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Alitalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2890-7790","authenticated-orcid":false,"given":"Michael","family":"Jeltsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,7]]},"reference":[{"key":"4982_CR1","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/nm.2545","volume":"17","author":"K Alitalo","year":"2011","unstructured":"Alitalo, K. The lymphatic vasculature in disease. Nature Medicine \n                           17, 1371\u20131380 (2011).","journal-title":"Nature Medicine"},{"key":"4982_CR2","first-page":"30","volume":"17","author":"R Krebs","year":"2013","unstructured":"Krebs, R. & Jeltsch, M. The lymphangiogenic growth factors VEGF-C and VEGF-D Part 1: Basic principles and embryonic development. LymphForsch \n                           17, 30\u201337 (2013).","journal-title":"LymphForsch"},{"key":"4982_CR3","first-page":"96","volume":"17","author":"R Krebs","year":"2013","unstructured":"Krebs, R. & Jeltsch, M. The lymphangiogenic growth factors VEGF-C and VEGF-D Part 2: The role of lymphangiogenic growth factors VEGF-C and VEGF-D in lymphatic disorders. LymphForsch \n                           17, 96\u2013104 (2013).","journal-title":"LymphForsch"},{"key":"4982_CR4","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1093\/emboj\/16.13.3898","volume":"16","author":"V Joukov","year":"1997","unstructured":"Joukov, V. et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. The EMBO Journal \n                           16, 3898\u20133911 (1997).","journal-title":"The EMBO Journal"},{"key":"4982_CR5","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1242\/dev.084152","volume":"140","author":"JA Villefranc","year":"2013","unstructured":"Villefranc, J. A. et al. A truncation allele in vascular endothelial growth factor c reveals distinct modes of signaling during lymphatic and vascular development. Development \n                           140, 1497\u20131506 (2013).","journal-title":"Development"},{"key":"4982_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1136\/jmedgenet-2013-102020","volume":"51","author":"E Balboa-Beltran","year":"2014","unstructured":"Balboa-Beltran, E. et al. A novel stop mutation in the vascular endothelial growth factor-C gene (VEGFC) results in Milroy-like disease. Journal of Medical Genetics \n                           51, 475\u2013478 (2014).","journal-title":"Journal of Medical Genetics"},{"key":"4982_CR7","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1161\/01.RES.0000269042.58594.f6","volume":"100","author":"S Keskitalo","year":"2007","unstructured":"Keskitalo, S. et al. Enhanced capillary formation stimulated by a chimeric vascular endothelial growth factor\/vascular endothelial growth factor-C silk domain fusion protein. Circulation Research \n                           100, 1460\u20131467 (2007).","journal-title":"Circulation Research"},{"key":"4982_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/75997","volume":"25","author":"MJ Karkkainen","year":"2000","unstructured":"Karkkainen, M. J. et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nature Genetics \n                           25, 153\u2013159 (2000).","journal-title":"Nature Genetics"},{"key":"4982_CR9","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1161\/CIRCRESAHA.113.300350","volume":"112","author":"K Gordon","year":"2013","unstructured":"Gordon, K. et al. Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant Milroy-like primary lymphedema. Circulation Research \n                           112, 956\u2013960 (2013).","journal-title":"Circulation Research"},{"key":"4982_CR10","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/ng.484","volume":"41","author":"M Alders","year":"2009","unstructured":"Alders, M. et al. Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nature Genetics \n                           41, 1272\u20131274 (2009).","journal-title":"Nature Genetics"},{"key":"4982_CR11","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1172\/JCI83967","volume":"126","author":"HM Bui","year":"2016","unstructured":"Bui, H. M. et al. Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD. Journal of Clinical Investigation \n                           126, 2167\u20132180 (2016).","journal-title":"Journal of Clinical Investigation"},{"key":"4982_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1161\/CIRCRESAHA.111.250738","volume":"109","author":"FL Bos","year":"2011","unstructured":"Bos, F. L. et al. CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo. Circulation Research \n                           109, 486\u2013491 (2011).","journal-title":"Circulation Research"},{"key":"4982_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ni1013","volume":"5","author":"MJ Karkkainen","year":"2004","unstructured":"Karkkainen, M. J. et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nature Immunology. \n                           5, 74\u201380 (2004).","journal-title":"Nature Immunology."},{"key":"4982_CR14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000342486","volume":"4","author":"M Alders","year":"2012","unstructured":"Alders, M. et al. Evaluation of clinical manifestations in patients with severe lymphedema with and without CCBE1 mutations. Molecular Syndromology \n                           4, 107\u201311 (2012).","journal-title":"Molecular Syndromology"},{"key":"4982_CR15","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1161\/CIRCRESAHA.116.304949","volume":"116","author":"MG Roukens","year":"2015","unstructured":"Roukens, M. G. et al. Functional dissection of the CCBE1 protein: A crucial requirement for the collagen repeat domain. Circulation Research \n                           116, 1660\u20131669 (2015).","journal-title":"Circulation Research"},{"key":"4982_CR16","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1161\/CIRCULATIONAHA.113.002779","volume":"129","author":"M Jeltsch","year":"2014","unstructured":"Jeltsch, M. et al. CCBE1 enhances lymphangiogenesis via a disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation. Circulation \n                           129, 1962\u20131971 (2014).","journal-title":"Circulation"},{"key":"4982_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10456-015-9488-z","volume":"19","author":"L Janssen","year":"2016","unstructured":"Janssen, L. et al. ADAMTS3 activity is mandatory for embryonic lymphangiogenesis and regulates placental angiogenesis. Angiogenesis \n                           19, 53\u201365 (2016).","journal-title":"Angiogenesis"},{"key":"4982_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1161\/CIRCRESAHA.116.308504","volume":"119","author":"SC Johns","year":"2016","unstructured":"Johns, S. C. et al. Functional importance of a proteoglycan coreceptor in pathologic lymphangiogenesis. Circulation Research \n                           119, 210\u2013221 (2016).","journal-title":"Circulation Research"},{"key":"4982_CR19","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1387\/ijdb.113394jf","volume":"55","author":"J Facucho-Oliveira","year":"2011","unstructured":"Facucho-Oliveira, J., Bento, M. & Belo, J. Ccbe1 expression marks the cardiac and lymphatic progenitor lineages during early stages of mouse development. International Journal of Developmental Biology \n                           55, 1007\u20131014 (2011).","journal-title":"International Journal of Developmental Biology"},{"key":"4982_CR20","doi-asserted-by":"publisher","first-page":"e0164964","DOI":"10.1371\/journal.pone.0164964","volume":"11","author":"V Hasselhof","year":"2016","unstructured":"Hasselhof, V. et al. Morphological and molecular characterization of human dermal lymphatic collectors. PLoS ONE \n                           11, e0164964 (2016).","journal-title":"PLoS ONE"},{"key":"4982_CR21","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1593\/neo.07643","volume":"9","author":"GM Nelson","year":"2007","unstructured":"Nelson, G. M., Padera, T. P., Garkavtsev, I., Shioda, T. & Jain, R. K. Differential gene expression of primary cultured lymphatic and blood vascular endothelial cells. Neoplasia \n                           9, 1038\u20131045 (2007).","journal-title":"Neoplasia"},{"key":"4982_CR22","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1186\/bcr3415","volume":"15","author":"M Riaz","year":"2013","unstructured":"Riaz, M. et al. miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs. Breast Cancer Research \n                           15, R33 (2013).","journal-title":"Breast Cancer Research"},{"key":"4982_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature \n                           536, 285\u2013291 (2016).","journal-title":"Nature"},{"key":"4982_CR24","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/ng.321","volume":"41","author":"BM Hogan","year":"2009","unstructured":"Hogan, B. M. et al. ccbe1 is required for embryonic lymphangiogenesis and venous sprouting. Nature Genetics \n                           41, 396\u2013398 (2009).","journal-title":"Nature Genetics"},{"key":"4982_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/jcp.20106","volume":"202","author":"X Zhang","year":"2005","unstructured":"Zhang, X., Groopman, J. E. & Wang, J. F. Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin \u03b15\u03b21. Journal of Cellular Physiology \n                           202, 205\u2013214 (2005).","journal-title":"Journal of Cellular Physiology"},{"key":"4982_CR26","doi-asserted-by":"publisher","first-page":"41950","DOI":"10.1074\/jbc.M101370200","volume":"276","author":"JF Wang","year":"2001","unstructured":"Wang, J. F. Stimulation of \u03b21 integrin induces tyrosine phosphorylation of vascular endothelial growth factor receptor-3 and modulates cell migration. Journal of Biological Chemistry \n                           276, 41950\u201341957 (2001).","journal-title":"Journal of Biological Chemistry"},{"key":"4982_CR27","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1101\/gad.242002","volume":"16","author":"C Ruhrberg","year":"2002","unstructured":"Ruhrberg, C. et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes & Development \n                           16, 2684\u20132698 (2002).","journal-title":"Genes & Development"},{"key":"4982_CR28","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1083\/jcb.200302047","volume":"161","author":"H Gerhardt","year":"2003","unstructured":"Gerhardt, H. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. The Journal of Cell Biology \n                           161, 1163\u20131177 (2003).","journal-title":"The Journal of Cell Biology"},{"key":"4982_CR29","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1084\/jem.20030361","volume":"198","author":"BK McColl","year":"2003","unstructured":"McColl, B. K. et al. Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D. The Journal of Experimental Medicine \n                           198, 863\u2013868 (2003).","journal-title":"The Journal of Experimental Medicine"},{"key":"4982_CR30","doi-asserted-by":"publisher","first-page":"25791","DOI":"10.1074\/jbc.M001065200","volume":"275","author":"M Tortorella","year":"2000","unstructured":"Tortorella, M. et al. The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage. Journal of Biological Chemistry \n                           275, 25791\u201325797 (2000).","journal-title":"Journal of Biological Chemistry"},{"key":"4982_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/humu.21143","volume":"31","author":"LA Lotta","year":"2010","unstructured":"Lotta, L. A., Garagiola, I., Palla, R., Cairo, A. & Peyvandi, F. ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura. Human Mutation \n                           31, 11\u201319 (2010).","journal-title":"Human Mutation"},{"key":"4982_CR32","doi-asserted-by":"publisher","first-page":"e77117","DOI":"10.1371\/journal.pone.0077117","volume":"8","author":"CH Lieu","year":"2013","unstructured":"Lieu, C. H. et al. The association of alternate VEGF ligands with resistance to Anti-VEGF therapy in metastatic colorectal cancer. PLoS ONE \n                           8, e77117 (2013).","journal-title":"PLoS ONE"},{"key":"4982_CR33","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1046\/j.1432-1327.2000.01257.x","volume":"267","author":"MG Achen","year":"2000","unstructured":"Achen, M. G. et al. Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3. European Journal of Biochemistry \n                           267, 2505\u20132515 (2000).","journal-title":"European Journal of Biochemistry"},{"key":"4982_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/84651","volume":"7","author":"T M\u00e4kinen","year":"2001","unstructured":"M\u00e4kinen, T. et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nature Medicine \n                           7, 199\u2013205 (2001).","journal-title":"Nature Medicine"},{"key":"4982_CR35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1172\/JCI200522037","volume":"115","author":"P Baluk","year":"2005","unstructured":"Baluk, P. et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. The Journal of Clinical Investigation \n                           115, 247\u2013257 (2005).","journal-title":"The Journal of Clinical Investigation"},{"key":"4982_CR36","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1182\/blood-2004-08-3327","volume":"105","author":"T Tammela","year":"2005","unstructured":"Tammela, T. Angiopoietin-1 promotes lymphatic sprouting and hyperplasia. Blood \n                           105, 4642\u20134648 (2005).","journal-title":"Blood"},{"key":"4982_CR37","doi-asserted-by":"publisher","first-page":"12960","DOI":"10.1073\/pnas.1301415110","volume":"110","author":"V-M Leppanen","year":"2013","unstructured":"Leppanen, V.-M. et al. Structural and mechanistic insights into VEGF receptor 3 ligand binding and activation. Proceedings of the National Academy of Sciences \n                           110, 12960\u201312965 (2013).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"4982_CR38","doi-asserted-by":"publisher","first-page":"5962","DOI":"10.1038\/ncomms6962","volume":"6","author":"L Hakanpaa","year":"2015","unstructured":"Hakanpaa, L. et al. Endothelial destabilization by angiopoietin-2 via integrin \u03b21 activation. Nature Communications \n                           6, 5962 (2015).","journal-title":"Nature Communications"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-04982-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-04982-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-04982-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T06:29:56Z","timestamp":1671776996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-04982-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,7]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["4982"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-04982-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,7]]},"assertion":[{"value":"12 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4916"}}